
Two cities in Scotland named among UK's most ‘sleep-deprived' regions
Two Scottish cities have been named two of the UK's most sleep-deprived cities, according to a new report by sleep specialists at MattressNextDay. The study found both cities ranked in the top five for poor sleep, with Glasgow scoring 82.52 out of 100 and Edinburgh close behind at 82.22.
The report comes amid a sharp rise in sleep-related health issues, with cases of sleep apnoea having surged by 214 percent over the past decade. Meanwhile, one in three people across the UK are now thought to suffer from insomnia.
To determine the most sleepless regions in the country, researchers created a sleep deprivation index, analysing a range of environmental, behavioural and health factors across 332 local authorities.
This included NHS data on sleep disorder hospital admissions, the density of nightlife venues, levels of light pollution and household spending on caffeine.
In Scotland, both Glasgow and Edinburgh share some of the same sleep-disrupting traits. Glasgow is home to 21 nightlife venues per 100,000 people, while Edinburgh has 27, contributing to higher noise levels and more artificial light exposure during the night.
In 2022, both cities also recorded their highest-ever levels of night-time light pollution: 124.49 nW·cm⁻²·sr⁻¹ in Glasgow and 111.88 in Edinburgh.
The caffeine culture is another major contributor. Households in Glasgow and Edinburgh combined spent over £59 million on caffeinated products, which can delay the onset of sleep and reduce overall sleep quality.
Sleep-related hospital admissions were also concerning, with Glasgow recording 256 patients annually and Edinburgh 215.
Martin Seeley, senior sleep expert at MattressNextDay, said: 'A high concentration of nightlife venues and artificial light can significantly impact the sleep of residents. Too much light and noise at night can harm our sleep and exacerbate pre-existing sleep conditions, such as insomnia and sleep apnoea.
'In fact, research has shown residents living close to lively 'night-time economy' streets report significantly more awakenings, poorer self-rated sleep and knock-on health complaints than those in quieter areas.
"Not only this, but light pollution is known to disrupt the circadian rhythm by reducing the secretion of melatonin, otherwise known as the 'sleep hormone'.'
Outside of Scotland, Nottingham was revealed as the UK's most sleep-deprived city with a score of 90.97.
Join the Daily Record WhatsApp community!
Get the latest news sent straight to your messages by joining our WhatsApp community today.
You'll receive daily updates on breaking news as well as the top headlines across Scotland.
No one will be able to see who is signed up and no one can send messages except the Daily Record team.
All you have to do is click here if you're on mobile, select 'Join Community' and you're in!
If you're on a desktop, simply scan the QR code above with your phone and click 'Join Community'.
We also treat our community members to special offers, promotions, and adverts from us and our partners. If you don't like our community, you can check out any time you like.
To leave our community click on the name at the top of your screen and choose 'exit group'.
If you're curious, you can read our Privacy Notice.
The city recorded the highest number of nightlife venues at 28 per 100,000 people, as well as some of the most intense light pollution. Around 129 residents are hospitalised annually due to sleep-related conditions.
Two regions in Yorkshire also made the top 10. East Riding of Yorkshire had a relatively low number of nightlife venues but reported a light pollution level of 232.73, one of the highest in the study.
North Yorkshire also ranked high due to its caffeine spend of £31.69 million and 253 annual hospital admissions, second only to Leeds in England. In the South West, Bristol and Somerset were among the worst-affected areas.
Bristol had 25 nightlife venues per 100,000 residents, while Somerset recorded the brightest single night in the UK study at 394.68 nW·cm⁻²·sr⁻¹, nearly four times brighter than London's most illuminated night.
Rank
Local Authority
Nightlife venues *
Household spend on caffeine **
Light
pollution ***
NHS sleep disorder hospital episodes ****
Sleep deprivation score (/100)
1
Nottingham
28
16.17
78
129
90.97
2
Newcastle upon Tyne
23
15.52
307.38
124
87.13
3
Glasgow
21
32.13
124.49
256
82.52
4
Edinburgh
27
26.89
111.88
215
82.22
5
Wigan
10
16.61
38.12
133
72.85
6
East Riding of Yorkshire
5
17.74
232.73
142
71.90
7
Bristol
25
24.11
103.08
192
71.75
8
North Yorkshire
11
31.69
59.64
253
70.15
9
Somerset
7
29.04
394.68
232
69.85
10
York
16
10.59
56.01
Article continues below
85
67.77

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
12 minutes ago
- The Independent
NHS issues vaccination warning for pregnant women over dangerous virus currently surging in Australia
Expectant mothers and people over 75 are being urged to get vaccinated against a potentially deadly virus following a record number of cases in Australia. Health chiefs say the Australian winter often predicts how viruses will spread in the UK, and already this year cases of respiratory syncytial virus (RSV) have steadily risen in many areas. The virus, which is a common cause of coughs and colds, may also cause a chest infection called bronchiolitis. Some people have a high risk of becoming seriously ill with it, including babies and adults over 75. According to NHS England, RSV is a leading cause of infant deaths worldwide and a main cause of children being taken into hospital. Last winter, almost 7,000 bed days in England were taken up by children with RSV. NHS England is encouraging pregnant women to get a jab that protects against RSV so their babies are protected after birth. Kate Brintworth, chief midwifery officer for NHS England, said: 'While for most adults RSV only causes mild, cold-like symptoms, for older adults and young children it can lead to serious breathing problems that can end up in hospitalisation. 'Getting vaccinated while pregnant is the best way to protect your baby from the moment they are born, and now is the time for mums to act, to make sure their babies are protected ahead of their first few months this winter, when there tends to be more bugs circulating.' Yusra Osman says that when her son, Zakariya, was three months old, he developed bronchiolitis from the virus. He had a fever and was gasping for breath. The 34-year-old, from north London, said: 'Everything was a blur, but I remember his chest was caving in and out and he was really struggling to catch his breath.' Nurses found her son's oxygen levels were dangerously low. Ms Osman, a student midwife, said: 'That was one of those things you don't want to hear as a mum. He was crying, and we kept trying to put an oxygen mask on, but he was fighting to get it off and didn't want to be touched.' Zakariya, who is now seven, needed oxygen and a feeding tube in hospital. 'It's a mum's worst nightmare. Had the RSV vaccine been available then, I'd definitely have had it,' Ms Osman said. The RSV vaccine was offered to pregnant women in England for the first time last September and health officials say it has since helped to protect more than 300,000 mothers and babies. Pregnant mothers from 28 weeks onwards are eligible, as are adults aged 75 to 79. In the coming weeks, NHS England is set to invite more than a million people to have a jab, before the season for infections, which starts in October. Greta Hayward, consultant midwife at the UK Health Security Agency, said babies born in late summer or the autumn are most likely to be admitted to hospital with the virus. 'Hundreds of babies attend emergency departments each day for bronchiolitis through most of November and December,' she said.


The Guardian
43 minutes ago
- The Guardian
OpenAI changes ChatGPT to stop it telling people to break up with partners
ChatGPT will not tell people to break up with their partner and will encourage users to take breaks from long chatbot sessions, under new changes to the artificial intelligence tool. OpenAI, ChatGPT's developer, said the chatbot would stop giving definitive answers to personal challenges and would instead help people mull over issues such as breakups. 'When you ask something like: 'Should I break up with my boyfriend?' ChatGPT shouldn't give you an answer. It should help you think it through – asking questions, weighing pros and cons,' said OpenAI. The US company said new ChatGPT behaviour for dealing with 'high-stakes personal decisions' would be rolling out soon. OpenAI admitted this year that an update to ChatGPT had made the groundbreaking chatbot too agreeable and altered its tone. In one reported interaction before the change, ChatGPT congratulated a user for 'standing up for yourself' when they claimed they had stopped taking their medication and left their family – who were supposedly 'responsible' for radio signals emanating from the walls. In the blog post OpenAI admitted there had been instances where its advanced 4o model had not recognised signs of delusion or emotional dependency – amid concerns that chatbots are worsening people's mental health crises. The company said it was developing tools to detect signs of mental or emotional distress so ChatGPT can direct people to 'evidence-based' resources for help. A recent study by NHS doctors in the UK warned that AI programs could amplify delusional or grandiose content in users vulnerable to psychosis. The study, which has not been peer reviewed, said this could be due in part to the models being designed to 'maximise engagement and affirmation'. The study added that even if some individuals benefitted from AI interactions, there was a concern the tools could 'blur reality boundaries and disrupt self-regulation'. OpenAI added that from this week it would send 'gentle reminders' to take a screen break to users engaging in long chatbot sessions, similar to screen-time features deployed by social media companies. OpenAI said it had convened an advisory group of experts in mental health, youth development and human-computer-interaction to guide its approach. The company has worked with more than 90 doctors including psychiatrists and paediatricians to build frameworks for evaluating 'complex, multi-turn' chatbot conversations. 'We hold ourselves to one test: if someone we love turned to ChatGPT for support, would we feel reassured? Getting to an unequivocal 'yes' is our work,' said the blog post. The ChatGPT alterations were announced amid speculation that a more powerful version of the chatbot is imminent. On Sunday Sam Altman, OpenAI's chief executive, shared a screenshot of what appeared to be the company's latest AI model, GPT-5.


The Independent
an hour ago
- The Independent
Thousands of patients miss out on weight loss jab due to NHS ‘postcode lottery'
Thousands of obese patients are missing out on a key weight loss jab due to a 'postcode lottery' of provision in the NHS, according to a report. Mounjaro, dubbed the 'King Kong' of weight loss medicine, was supposed to be available through GP surgeries from 23 June under an agreement between NHS England and NICE. But just eight out of 42 NHS Integrated Care Boards (ICBs) in England were able to provide treatment to patients, according to Sky News, who obtained the data using a Freedom of Information request. Many other ICBs were reportedly unable to confirm when treatment would be available. Dr Jonathan Hazlehurst, an endocrinologist and obesity physician at University Hospitals Birmingham, said patients were 'set up for failure' and have been treated unfairly. "Giving people open promises and setting them up for disappointment and failure is clearly grossly unfair. That's what the current system is doing,' he told the broadcaster. NICE said in December that the NHS should offer Mounjaro to patients with a BMI of over 40 and at least four clinical conditions related to their weight, such as heart disease or type 2 diabetes. It calculated from NHS England data that there were 97,500 patients who should be treated in the first year. But Dr Hazlehurst claims NHS England has only provided funding for just over 22,000 patients. The Independent has approached NHS England for comment. A spokesperson told Sky News that NHS England had "fully supported the rollout" of Mounjaro. "We issued guidance and provided funding in March to all Integrated Care Boards to support treatment costs, enable scaling of services and provide wrap-around care, including digital support services,' they said. It comes after NICE warned many individuals might regain weight if not adequately supported after ceasing treatment. It stressed that those coming off the drugs should be offered "structured advice and follow-up support" to mitigate weight gain. This guidance applies to individuals receiving these treatments through the NHS. However, an estimated 1.5 million people in the UK are currently using weight-loss injections, with the vast majority paying privately. These individuals will not be eligible for NHS support once their treatment concludes. The new 'quality standard' from NICE says that NHS patients should be monitored for at least a year after they complete treatment, and extra support should be offered if needed. It emphasises building 'long-term behavioural habits, use self-monitoring tools, and draw on wider support – from online communities to family-led interventions and local activities'. This standard, a type of guidance for the health services in England and Wales, sets out expectations for health providers including how they should support patients. 'Successful weight management doesn't end when medication stops or when someone completes a behavioural programme,' said Professor Jonathan Benger, deputy chief executive and chief medical officer at Nice. 'We know that the transition period after treatment is crucial, and people need structured support to maintain the positive changes they've made.'